AJDRAJNR - American Journal of Neuroradiology

Published ahead of print on December 4, 2008
doi: 10.3174/ajnr.A1377

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Online Tables
Right arrow All Versions of this Article:
ajnr.A1377v1
30/3/552    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hu, L.S.
Right arrow Articles by Heiserman, J.E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, L.S.
Right arrow Articles by Heiserman, J.E.

BRAIN

Relative Cerebral Blood Volume Values to Differentiate High-Grade Glioma Recurrence from Posttreatment Radiation Effect: Direct Correlation between Image-Guided Tissue Histopathology and Localized Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging Measurements

L.S. Hua,g, L.C. Baxterc, K.A. Smithd, B.G. Feuersteine, J.P. Karisb, J.M. Eschbacherf, S.W. Coonsf, P. Nakajid, R.F. Yehh, J. Debbinsg and J.E. Heisermanb

a Department of Radiology, Mayo Clinic, Phoenix/Scottsdale, Ariz
b Department of Neuroradiology, Barrow Neurological Institute, Phoenix, Ariz
c Department of Neuropsychology Neuroimaging Laboratory, Barrow Neurological Institute, Phoenix, Ariz
d Department of Neurosurgery, Barrow Neurological Institute, Phoenix, Ariz
e Department of Neurology, Barrow Neurological Institute, Phoenix, Ariz
f Department of Neuropathology, Barrow Neurological Institute, Phoenix, Ariz
g Keller Center for Imaging Innovation, Barrow Neurological Institute, Phoenix, Ariz
h Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, Calif

Please address correspondence to Leland S. Hu, MD, Department of Radiology, Mayo Clinic, 13400 E. Shea Blvd, Scottsdale, AZ 85259; e-mail: Hu.Leland{at}Mayo.Edu

BACKGROUND AND PURPOSE: Differentiating tumor growth from posttreatment radiation effect (PTRE) remains a common problem in neuro-oncology practice. To our knowledge, useful threshold relative cerebral blood volume (rCBV) values that accurately distinguish the 2 entities do not exist. Our prospective study uses image-guided neuronavigation during surgical resection of MR imaging lesions to correlate directly specimen histopathology with localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging (DSC) measurements and to establish accurate rCBV threshold values, which differentiate PTRE from tumor recurrence.

MATERIALS AND METHODS: Preoperative 3T gradient-echo DSC and contrast-enhanced stereotactic T1-weighted images were obtained in patients with high-grade glioma (HGG) previously treated with multimodality therapy. Intraoperative neuronavigation documented the stereotactic location of multiple tissue specimens taken randomly from the periphery of enhancing MR imaging lesions. Coregistration of DSC and stereotactic images enabled calculation of localized rCBV within the previously recorded specimen locations. All tissue specimens were histopathologically categorized as tumor or PTRE and were correlated with corresponding rCBV values. All rCBV values were T1-weighted leakage-corrected with preload contrast-bolus administration and T2/T2*-weighted leakage-corrected with baseline subtraction integration.

RESULTS: Forty tissue specimens were collected from 13 subjects. The PTRE group (n = 16) rCBV values ranged from 0.21 to 0.71, tumor (n = 24) values ranged from 0.55 to 4.64, and 8.3% of tumor rCBV values fell within the PTRE group range. A threshold value of 0.71 optimized differentiation of the histopathologic groups with a sensitivity of 91.7% and a specificity of 100%.

CONCLUSIONS: rCBV measurements obtained by using DSC and the protocol we have described can differentiate HGG recurrence from PTRE with a high degree of accuracy.




This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
L.S. Hu, L.C. Baxter, D.S. Pinnaduwage, T.L. Paine, J.P. Karis, B.G. Feuerstein, K.M. Schmainda, A.C. Dueck, J. Debbins, K.A. Smith, et al.
Optimized Preload Leakage-Correction Methods to Improve the Diagnostic Accuracy of Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging in Posttreatment Gliomas
AJNR Am. J. Neuroradiol., January 1, 2010; 31(1): 40 - 48.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
R. F. Barajas Jr, J. S. Chang, M. R. Segal, A. T. Parsa, M. W. McDermott, M. S. Berger, and S. Cha
Differentiation of Recurrent Glioblastoma Multiforme from Radiation Necrosis after External Beam Radiation Therapy with Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging
Radiology, November 1, 2009; 253(2): 486 - 496.
[Abstract] [Full Text] [PDF]